In September 2016 the South African Institute for Drugfree Sport (SAIDS) has reported an anti-doping rule violation against the cyclist Mark Doffay after his sample tested positive for the prohibited substances 5α-androstane-3α,17β-diol and 5β-androstane-3α,17β-diol (Testosterone). After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the SAIDS Anti-Doping Disciplinary Panel.
The Athlete accepted the test results and stated that he had used prescribed medication containing these substances in 2016 as treatment for his excessively low testosterone levels and not to enhance his sport performance. When administered the medication would last for 3 months in his system and his doctor was not informed that he was a competitive cyclist.
The Athlete acknowledged that he failed to apply for a TUE and he didn’t mention his medication on the Doping Control Form. He admitted that the medication did effect his performance in cycling although it was used solely as medical treatment. After he tested positive the Athlete’s application for a retroactive TUE was denied.
The Panel considers the Athlete conduct and failures in this case and finds that the Athlete was aware that he used medication that contained the prohibited substance and as a result that he is guilty of committing an anti-doping rule violation without grounds for a reduced sanction.
Therefore the Anti-Doping Disciplinary Panel decides on 15 December 2017 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension i.e. on 26 September 2016.